Mimedx Group Inc is a biotech company focused on the development and commercialization of regenerative medicine products, particularly those that utilize allogeneic placental tissues
The company aims to provide advanced solutions for wound care, surgical applications, and orthopedic treatments through its innovative therapies that promote healing and tissue regeneration. Mimedx's products are designed to support patient recovery by harnessing the natural properties of human placental tissues, thereby enhancing the body’s own healing processes. By combining scientific expertise with cutting-edge technology, Mimedx is committed to improving patient outcomes in various medical fields.
AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Board of Directors has appointed Richard (Rick) Barry as Executive Chairman of the Board and as the Company’s principal executive officer, effective immediately. The Company is undertaking a search for a new permanent CEO.
Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery. Targeting a $3.9 billion market, MIMEDX products demonstrate a 97% wound closure rate for diabetic foot ulcers, cost-effectiveness, and significant growth potential.
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MiMedx Group, Inc. (NASDAQMDXG) resulting from allegations that MiMedx may have issued materially misleading business information to the investing public.
NEW YORK, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQMDXG) on behalf of MiMedx stockholders. Our investigation concerns whether MiMedx has violated the federal securities laws and/or engaged in other unlawful business practices.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQMDXG) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQMDXG) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQMDXG) on behalf of investors concerning the Company’s possible violations of federal securities laws.
U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.
